Details for New Drug Application (NDA): 071425
✉ Email this page to a colleague
NDA 071425 describes DESOWEN, which is a drug marketed by Galderma Labs Lp and is included in three NDAs. It is available from four suppliers. Additional details are available on the DESOWEN profile page.
The generic ingredient in DESOWEN is desonide. There are thirty-one drug master file entries for this compound. Eighteen suppliers are listed for this compound. Additional details are available on the desonide profile page.
The generic ingredient in DESOWEN is desonide. There are thirty-one drug master file entries for this compound. Eighteen suppliers are listed for this compound. Additional details are available on the desonide profile page.
Summary for 071425
| Tradename: | DESOWEN |
| Applicant: | Galderma Labs Lp |
| Ingredient: | desonide |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 071425
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | OINTMENT;TOPICAL | Strength | 0.05% | ||||
| Approval Date: | Jun 15, 1988 | TE: | AB | RLD: | No | ||||
Complete Access Available with Subscription
